SARS-CoV-2 (COVID19) irakaze hirya no hino ku isi, kandi inkingo izwi nk'uburyo bwubukungu kandi bunoze bwo kurwanya icyorezo cya virusi.Isuzuma ryinkingo gakondo ahanini rikoresha uburyo bwo kutabuza antibody uburyo bwo gusuzuma imikorere yinkingo hakoreshejwe ubushakashatsi bwo kutabogama;
Uburyo gakondo butwara igihe kandi buke mubikorwa, mubisanzwe bifata iminsi 2 kugeza kuri 4 kugirango urangize isuzuma, kandi kubera ko inyinshi murizo zikoresha virusi nzima, Igomba gukorwa murwego rwa biosafeti kurwego rwa 3 cyangwa hejuru ya laboratoire, nigihe- kumara no gukora cyane, kandi bizana ikibazo gikomeyeku isuzuma ryo kwaguka no kwegeranya.Kubwibyo, harakenewe byihutirwa ubundi buryo bworoshye kandi bwihuse bwuburyo bukwiranye no gusuzuma antibodiyide zirinda abantu benshi.
Aehealth COVID19 Kutabogama Antibody Rapid Test Kits ikoreshwa mugutahura antibodiyite za COVID19 zidafite aho zibogamiye muri serumu yumuntu, plasma cyangwa mumaraso yose.Irashobora gukoreshwa muburyo bwihuse, bworoshye cyane muri vitro.mubuvuzi bukoreshwa mugusuzuma ubufasha bwingaruka zinkingo ya COVID19 no gusuzuma antibodiyite zidafite aho zibogamiye kubarwayi bakize nyuma yo kwandura.
Igikorwa cyoroshye
- Ntabwo ukeneye abanyamwuga guhugurwa
- Bihujwe nubwoko butandukanye bwikigereranyo: Serumu / Plasma / Amaraso yose / urutoki rwamaraso yose.
Byoroshye
- Nta gikoresho gisabwa
Ingirakamaro
- Ikizamini: iminota 15-20;
Antibodies zidafite aho zibogamiye zihagarika kwandura muguhagarika imikoranire hagati ya virusi ya COVID19 na selile zakira.Antibodiyite nyinshi zidafite aho zibogamiye zisubiza reseptor ihuza domeni (RBD) ya proteine ya spike, ihuza neza na selile ACE2.antibodies-kumurongo kuri ubu itanga antibodies ebyiri zidafite aho zibogamiye zishingiye kuri clone CR3022.Mugihe antibodiyite nyinshi za S-protein RBD zihatanira guhuza antigen hamwe na ACE2, epitope CR3022 ntabwo ihura na site ya ACE2 ihuza.
Ntabwo rero bibuza guhuza antibodiyite.Mugihe CR3022 yonyine yerekana ingaruka zidafite aho zibogamiye gusa, byagaragaye ko ihuza nizindi S-proteine RBD ihuza antibodiyite kugirango ibuze COVID19.
